ArticleCureus2024

Effective Treatment of Lung Adenocarcinoma With a Novel SLC44A1-BRAF Fusion Using Pembrolizumab Followed by Trametinib: A Case Report.

Sho Yasui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.